Immucell Corp (ICCC) Reports Q3 Loss of $0.09

Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of ($0.09). Revenue for the quarter came in at $6.01 million.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Tetra4 signs first helium supply deal for South Africa gas project
• Silo Pharma reports nine-month stability data for SPC-15 PTSD drug